SAN DIEGO, Nov. 28, 2017
SAN DIEGO, Nov. 28, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc. as detailed below:
INC Research Holdings, Inc.
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by INC Research Holdings, Inc. ("INC Research") (NASDAQ: INCR).
On November 9, 2017, INC Research reported its first financial results after merging with inVentiv Health. INC Research's combined results were adversely impacted by merger-related expenses, an impairment charge and increased amortization expenses. Following the news, INC Research stock fell significantly.
If you purchased INC Research common stock between May 1, 2017 and November 9, 2017 and are interested in learning more about your legal rights and remedies, please contact Jim Baker (firstname.lastname@example.org) at 619-814-4471. If you email, please include your phone number.
Acorda Therapeutics, Inc.
Shareholder Rights Law Firm Johnson Fistel, LLP today announced that it is investigating whether certain officers or directors of Acorda Therapeutics, Inc. ("Acorda") (NASDAQ: ACOR) violated federal or state laws.
A Securities Class Action Complaint was filed on behalf of those who purchased securities of Acorda between April 18, 2016 through November 14, 2017.
According to the lawsuit, defendants during the Class Period made materially false and misleading statements and failed to disclose that: (1) tozadenant entailed significant undisclosed safety risks; (2) accordingly, Acorda had overstated tozadenant's approval prospects and commercial viability; (3) for the foregoing reasons, Acorda had likewise overstated the benefits of the Biotie Acquisition; and (4) as a result, Acorda's shares traded at artificially inflated prices during the Class Period. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you wish to serve as a lead plaintiff, you must move the Court no later than January 17, 2018.
If you are a long-term shareholder of Acorda shares and continuously held shares before April 18, 2016, you may have standing to hold Acorda harmless from the damage the officers and directors may have caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.
If you are an Acorda shareholder and are interested in learning more about your legal rights and remedies, please contact Jim Baker (email@example.com) at 619-814-4471. If you email, please include your phone number.
Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Shopify Inc. ("Shopify") (NYSE: SHOP) and certain of its officers.
On October 4, 2017, Citron Research published a report describing Shopify as "a completely illegal get-rich quick scheme" and alleges that Shopify is engaging in business practices that are prohibited by the Federal Trade Commission. Following this news, Shopify's stock dropped over 11.00%.
If you have information that could assist in this investigation, including former employees and others, or if you are a Shopify shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (firstname.lastname@example.org) by email or by phone at 619-814-4471. If you email, please include your phone number.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
View original content:http://www.prnewswire.com/news-releases/johnson-fistel-announces-investigations-of-inc-research-holdings-inc-acorda-therapeutics-inc-and-shopify-inc-investors-encouraged-to-contact-firm-300562525.html
SOURCE Johnson Fistel, LLP